Using epidemiologic methods to study the uses, benefits, and harms of medical interventions to inform clinical decision-making and improve population health
Lund Research Group in JAMA Network Open and at the Triangle LUNGe Forward 5K
The Lund Research Group is proud to have joined the Tomma’s Tar Heelers team in fundraising and participating in the Lung Cancer Initiative 18th annual Triangle LUNGe Forward 5K Run, Walk and Celebration. LUNGe Forward events provide a day of hope, … Read more
Celebrating Pi(e) Day with the Pharmacoepidemiology Program
In observance of March 14th (3/14), Pi (π) Day, members of the Lund Research Group competed in a pie-bake-off at the 2nd Annual Pharmacoepidemiology Program Causal Pi(e) Day Celebration! The gathering, organized by the Pharmacoepidemiology Program’s very own Dr. Mollie Wood, showcased the talents of … Read more
Lund Research Group hosts a Lung Cancer Initiative gas card drive
Did you know that more than 8,000 people are diagnosed with lung cancer each year in North Carolina? Five-year survival for lung cancer has been improving, and is now 21%, thanks to research, screening and earlier diagnosis, and better treatment … Read more
CIPHR team receives $1.2 million grant to improve cancer screening mapping in NC
The American Cancer Society has awarded a five-year, $1.2 million Team Science grant to a group of UNC-Chapel Hill researchers who will develop new methods to measure and map cancer screening across North Carolina. TOP ROW, FROM LEFT: DRS. KATHERINE … Read more
